Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_assertion type Assertion NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_head.
- NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_assertion description "[Amounts of PGE1, PGE2, and PGF(2alpha), known substrates of 15-PGDH, were markedly increased whereas levels of 13,14-dihydro-15-keto-PGE2, a catabolic product of PGE2, were markedly reduced in NSCLC compared with normal lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_provenance.
- NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_assertion evidence source_evidence_literature NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_provenance.
- NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_assertion SIO_000772 19138967 NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_provenance.
- NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_assertion wasDerivedFrom befree-20140225 NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_provenance.
- NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_assertion wasGeneratedBy ECO_0000203 NP913884.RAhQdndRT9BDood1hPlPd4Kh0F71gG8fVrxNym-vCbCds130_provenance.